1-215999034-A-C
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM1BP4_StrongBP6_Very_StrongBS2
The NM_206933.4(USH2A):āc.6510T>Gā(p.Ser2170Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000332 in 1,612,508 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.6510T>G | p.Ser2170Arg | missense_variant | 34/72 | ENST00000307340.8 | NP_996816.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.6510T>G | p.Ser2170Arg | missense_variant | 34/72 | 1 | NM_206933.4 | ENSP00000305941 | P1 | |
USH2A | ENST00000674083.1 | c.6510T>G | p.Ser2170Arg | missense_variant | 34/73 | ENSP00000501296 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000863 AC: 216AN: 250296Hom.: 2 AF XY: 0.00106 AC XY: 144AN XY: 135286
GnomAD4 exome AF: 0.000350 AC: 511AN: 1460248Hom.: 7 Cov.: 32 AF XY: 0.000491 AC XY: 357AN XY: 726458
GnomAD4 genome AF: 0.000164 AC: 25AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74454
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 25, 2011 | Ser2170Arg in exon 34 of USH2A: This variant is not expected to have clinical si gnificance because the Serine 2170 residue is poorly conserved in mammals with m ost other species having an Asparagine. Therefore, this variant is likely benign . - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 14, 2016 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 01, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Usher syndrome type 2A Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Aug 18, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 04, 2023 | - - |
Retinitis pigmentosa 39 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 04, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at